Compare NGEN & FRBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NGEN | FRBA |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Major Banks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.6M | 377.6M |
| IPO Year | N/A | N/A |
| Metric | NGEN | FRBA |
|---|---|---|
| Price | $4.21 | $16.20 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $18.50 |
| AVG Volume (30 Days) | ★ 114.9K | 60.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.26% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $14.06 |
| Revenue Next Year | N/A | $5.86 |
| P/E Ratio | ★ N/A | $9.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.73 | $12.74 |
| 52 Week High | $5.93 | $18.11 |
| Indicator | NGEN | FRBA |
|---|---|---|
| Relative Strength Index (RSI) | 39.96 | 37.84 |
| Support Level | $3.73 | $15.07 |
| Resistance Level | $4.50 | $16.18 |
| Average True Range (ATR) | 0.25 | 0.50 |
| MACD | 0.05 | -0.13 |
| Stochastic Oscillator | 50.00 | 26.94 |
NervGen Pharma Corp is a clinical-stage biotech company. The company's principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291 and NVG-300.
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.